Chemours (CC) EBIAT (2016 - 2025)
Historic EBIAT for Chemours (CC) over the last 12 years, with Q3 2025 value amounting to $60.0 million.
- Chemours' EBIAT rose 28750.0% to $60.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$333.0 million, marking a year-over-year decrease of 62031.25%. This contributed to the annual value of $70.0 million for FY2024, which is 12941.18% up from last year.
- Per Chemours' latest filing, its EBIAT stood at $60.0 million for Q3 2025, which was up 28750.0% from -$381.0 million recorded in Q2 2025.
- Over the past 5 years, Chemours' EBIAT peaked at $240.0 million during Q3 2022, and registered a low of -$381.0 million during Q2 2025.
- For the 5-year period, Chemours' EBIAT averaged around $36.8 million, with its median value being $60.0 million (2024).
- As far as peak fluctuations go, Chemours' EBIAT surged by 112631.58% in 2021, and later crashed by 73500.0% in 2025.
- Quarter analysis of 5 years shows Chemours' EBIAT stood at $233.0 million in 2021, then tumbled by 141.63% to -$97.0 million in 2022, then soared by 81.44% to -$18.0 million in 2023, then soared by 55.56% to -$8.0 million in 2024, then soared by 850.0% to $60.0 million in 2025.
- Its EBIAT stands at $60.0 million for Q3 2025, versus -$381.0 million for Q2 2025 and -$4.0 million for Q1 2025.